TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33141609

Group type: COMPARATOR
Intervention: Empagliflozin (SGLT2 inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study: 33244331

Group type: EXPERIMENTAL
Intervention: Good knowledge about STIs
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Increased year of study
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Having one or no sexual partner
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Source of information from mass media (Television/Radio)
Number of subjects: 453
Study: 35428357

Group type: EXPERIMENTAL
Intervention: Interactive 4D-ultrasound intervention (three interactive ultrasound examinations)
Number of subjects: 100
Study: 32108382

Group type: EXPERIMENTAL
Intervention: Skin patches of Xin Huang Pian
Number of subjects: 61

Group type: COMPARATOR
Intervention: Diclofenac Diethylamine Emulgel
Number of subjects: 61
Study: 33453692

Group type: EXPERIMENTAL
Intervention: Reappraisal strategy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Distraction strategy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Acceptance strategy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control condition (no regulation)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: All conditions (skin conductance)
Number of subjects: 78
Study: 34844893

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Corticosteroid (CS; cortivazol) injection
Number of subjects: 36
Study: 33711748

Group type: EXPERIMENTAL
Intervention: Lavender essential oil massage (4 sessions)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study: 32876497

Group type: EXPERIMENTAL
Intervention: NI-RADS category 1
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS category 2a
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS category 2b
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS category 3
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS category 4
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS category 2
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: NI-RADS overall performance
Number of subjects: 158

Group type: EXPERIMENTAL
Intervention: Inter-reader agreement
Number of subjects: 158
Study: 35681488

Group type: EXPERIMENTAL
Intervention: Magnetic-Activated Cell Sorting (MACS) after density gradient centrifugation (DGC) in 90 thawed semen donor samples (MACSG)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Only density gradient centrifugation (DGC) in 91 thawed semen donor samples (CG)
Number of subjects: 181
Study: 32393152

Group type: EXPERIMENTAL
Intervention: Kin KeeperSM Cancer Prevention Intervention (culturally-targeted breast and cervical cancer literacy tool, two family-focused education sessions)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Highly communicative families
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Family history of cancer
Number of subjects: 516
Study: 34726121

Group type: EXPERIMENTAL
Intervention: Joint Resources–Sedentary Behaviour (JR‐SB) intervention
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Higher educational level and absence of comorbidity
Number of subjects: 467
Study: 34209833

Group type: EXPERIMENTAL
Intervention: tDCS (2‐mA current in the M1 area for 20 min)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham trial (current turned off after 5 s)
Number of subjects: 13
Study: 32576219

Group type: EXPERIMENTAL
Intervention: SD-101 6% cream
Number of subjects: 169

Group type: COMPARATOR
Intervention: Vehicle (0% allantoin)
Number of subjects: 169
Study: 35490136

Group type: EXPERIMENTAL
Intervention: Nonsurgical rapid maxillary expansion (RME)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Surgically assisted rapid maxillary expansion (SARME)
Number of subjects: 38
Study: 34379946

Group type: EXPERIMENTAL
Intervention: Proprietary combination (phenyl ethyl resorcinol, nonapeptide-1, aminoethyl phosphinic acid, antioxidants and sunscreen)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sunscreen alone
Number of subjects: 46
Study: 36212116

Group type: EXPERIMENTAL
Intervention: Counsellor-supported PTSD Coach Online (PCO)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Counsellor-supported PTSD Coach Mobile App
Number of subjects: 20

Group type: COMPARATOR
Intervention: Self-managed PTSD Coach Mobile App
Number of subjects: 20
Study: 34654903

Group type: EXPERIMENTAL
Intervention: Mydriatic microdrops (phenylephrine 1.67% and tropicamide 0.33%)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard drops (phenylephrine 1.67% and tropicamide 0.33%)
Number of subjects: 25
Study: 32019854

Group type: EXPERIMENTAL
Intervention: Reparixin
Number of subjects: 75
Study: 35711112

Group type: EXPERIMENTAL
Intervention: Cenobamate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34378307

Group type: EXPERIMENTAL
Intervention: BAX‐HI (1 U/mL)
Number of subjects: 58

Group type: COMPARATOR
Intervention: NOVO‐HI (100 U/mL diluted to 1 U/mL)
Number of subjects: 58
Study: 32512785

Group type: EXPERIMENTAL
Intervention: Warm-water immersion for 20 minutes
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cold-water immersion for 20 minutes
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Warm-water immersion
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cold-water immersion
Number of subjects: 12
Study: 32940132

Group type: EXPERIMENTAL
Intervention: Single-layer closure (SLC)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Triple-layer closure (TLC)
Number of subjects: 51
Study: 33577138

Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:6
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:8
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Instructor-to-student ratio of 1:10
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: All groups surveyed
Number of subjects: 121
Study: 35576285

Group type: EXPERIMENTAL
Intervention: Intra-articular Ketorolac
Number of subjects: 133

Group type: COMPARATOR
Intervention: Intra-articular Lignocaine
Number of subjects: 133
Study: 33800577

Group type: EXPERIMENTAL
Intervention: ME + BCAAs
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: ME
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: BCAAs
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 34890532

Group type: EXPERIMENTAL
Intervention: 12-week supervised exercise training programme (moderate intensity combination aerobic/resistance exercise training programme)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Supervised exercise training programme
Number of subjects: 59
Study: 36399379

Group type: EXPERIMENTAL
Intervention: Automated virtual reality cognitive therapy (gameChange)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 346
Study: 35870440

Group type: EXPERIMENTAL
Intervention: Moderated drinking recovery narrative
Number of subjects: 489

Group type: EXPERIMENTAL
Intervention: Continuous symptom narrative + Moderated drinking recovery narrative
Number of subjects: 489

Group type: COMPARATOR
Intervention: Dichotomous symptom narrative + Abstinence recovery narrative
Number of subjects: 489

Group type: COMPARATOR
Intervention: Continuous symptom narrative + Abstinence recovery narrative
Number of subjects: 489

Group type: COMPARATOR
Intervention: Dichotomous symptom narrative + Moderated drinking recovery narrative
Number of subjects: 489
Study: 33754400

Group type: EXPERIMENTAL
Intervention: Adventure-based training (2-day/1-night)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Placebo control group (2 days of leisure activities)
Number of subjects: 228
Study: 32200248

Group type: EXPERIMENTAL
Intervention: Follicular flushing with a double-lumen 17-gauge needle
Number of subjects: 252

Group type: COMPARATOR
Intervention: Direct aspiration with a single-lumen 17-gauge needle
Number of subjects: 252
Study: 35396311

Group type: EXPERIMENTAL
Intervention: CKD-related video decision aid followed by recording personal video declarations about goals of care and treatment preferences
Number of subjects: 600
Study: 35225371

Group type: EXPERIMENTAL
Intervention: DVP cutoff of 8 cm (DVP-Youden)
Number of subjects: 71893

Group type: EXPERIMENTAL
Intervention: DVP cutoff of 10 cm (DVP-Percentile)
Number of subjects: 71893

Group type: COMPARATOR
Intervention: DVP cutoffs compared against SMFM cutoffs (DVP-SMFM)
Number of subjects: 71893
Study: 32885568

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (2 g combined probiotics daily)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 28
Study: 34821494

Group type: EXPERIMENTAL
Intervention: Tai chi
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study: 32138760

Group type: EXPERIMENTAL
Intervention: ERAS care pathway
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional care pathway
Number of subjects: 60
Study: 32308074

Group type: EXPERIMENTAL
Intervention: LED irradiation for 24 sessions (3 sessions per week) in addition to standard medical treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard medical treatment for 8 weeks
Number of subjects: 30
Study: 33186337

Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil Fumarate (TDF) intravaginal ring (IVR)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo intravaginal ring (IVR)
Number of subjects: 17
Study: 33802634

Group type: EXPERIMENTAL
Intervention: GDP arm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DHAP arm
Number of subjects: 0
Study: 35943252

Group type: EXPERIMENTAL
Intervention: Rifapentine 600 mg daily (fixed dosing)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Weight-based dosing (10 mg/kg)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Efavirenz (EFV)-based ART
Number of subjects: 185

Group type: COMPARATOR
Intervention: Rifapentine and isoniazid regimen (1-month daily)
Number of subjects: 185
Study: 34321504

Group type: EXPERIMENTAL
Intervention: VR SHMD
Number of subjects: 58

Group type: COMPARATOR
Intervention: Smartphones
Number of subjects: 58
Study: 32036837

Group type: EXPERIMENTAL
Intervention: Rapamycin-eluting double stenting
Number of subjects: 126

Group type: COMPARATOR
Intervention: Rapamycin-eluting single stenting
Number of subjects: 126
Study: 34629430

Group type: EXPERIMENTAL
Intervention: Curettage + platelet-rich plasma gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Curettage + crystallized phenol
Number of subjects: 0
Study: 33932461

Group type: EXPERIMENTAL
Intervention: Diving method (500 mL of water administered every hour when the capsule reached the small bowel)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Diving method
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study: 35066365

Group type: EXPERIMENTAL
Intervention: Guided internet-based transdiagnostic individually tailored Cognitive Behavioral Therapy (iCBT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 100
Study: 35820845

Group type: EXPERIMENTAL
Intervention: Intervention group - open discussion about patients' Advance Directives
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group - evaluation of patients' clinical condition
Number of subjects: 58
Study: 34673844

Group type: EXPERIMENTAL
Intervention: Amine fluoride, stannous chloride (ASC) toothpaste slurry
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Herbal (SBC) toothpaste slurry
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (SFL) toothpaste slurry
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All toothpastes
Number of subjects: 24
Study: 32701116

Group type: EXPERIMENTAL
Intervention: Febuxostat 20 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no febuxostat)
Number of subjects: 0
Study: 35431205

Group type: EXPERIMENTAL
Intervention: Customized on-site exercise program including manual and exercise therapy from physiotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: Customized exercise sheets for a self-directed program at home
Number of subjects: 56
Study: 33762661

Group type: EXPERIMENTAL
Intervention: Caralluma Fimbriata extract (CFE)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 32877825

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Venlafaxine plus Quetiapine
Number of subjects: 122

Group type: COMPARATOR
Intervention: Psychomotor Retardation presence
Number of subjects: 122
Study: 35507447

Group type: EXPERIMENTAL
Intervention: Aerobic walking program (24 weeks)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (routine care)
Number of subjects: 58
Study: 34582575

Group type: EXPERIMENTAL
Intervention: Light (>500 lux) + exogenous melatonin (LSC)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Dark (<5 lux) + exogenous melatonin (DSC)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Light (>500 lux) (LS)
Number of subjects: 9
Study: 33539672

Group type: EXPERIMENTAL
Intervention: Intensive glucose lowering (target HbA1c concentration of ≤48 mmol/mol [6.5%])
Number of subjects: 11140
Study: 32489539

Group type: EXPERIMENTAL
Intervention: Medial Pivot (MP) TKA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Posterior-Stabilized (PS) TKA
Number of subjects: 80
Study: 34411745

Group type: EXPERIMENTAL
Intervention: Intensive patient education (two, one-hour treatment sessions)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo patient education (two, one-hour treatment sessions)
Number of subjects: 202
Study: 32932330

Group type: EXPERIMENTAL
Intervention: CYD‐TDV booster dose
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study: 35965825

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg/kg lidocaine 10 minutes prior to induction, followed by 2 mg/kg/h until the end of surgery)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (saline)
Number of subjects: 82
Study: 34967575

Group type: EXPERIMENTAL
Intervention: Kali Haldi and aloe vera gel mixture, 3 times a day for 3 months
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intralesional injection of hydrocortisone and hyaluronidase for 6 weeks with oral antioxidant supplements for 3 months
Number of subjects: 42
Study: 34559394

Group type: EXPERIMENTAL
Intervention: Low-dose hydrocortisone (10 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 34816727

Group type: EXPERIMENTAL
Intervention: Noninvasive monitoring strategies (serial 3 short-duration monitors: 24-/48-hour ECG monitors)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Noninvasive monitoring strategies (serial 3 longer-term monitors: 14-day ECG monitors)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Short-duration monitors
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Serial long-term (7-14 day) intermittent monitors accumulating at least 28 days of annual monitoring
Number of subjects: 346

Group type: COMPARATOR
Intervention: Implantable cardiac monitor (ICM)
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Monitoring duration
Number of subjects: 346
Study: 34323446

Group type: EXPERIMENTAL
Intervention: Preoperative optic nerve sheath diameter measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative optic nerve sheath diameter measurements
Number of subjects: 0
Study: 35636802

Group type: EXPERIMENTAL
Intervention: elobixibat (10 mg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 100
Study: 33844469

Group type: EXPERIMENTAL
Intervention: Temozolomide (150 mg/m2/day PO on days 1–5) and Irinotecan (50 mg/m2/day IV on days 1–5) plus Bevacizumab (10 mg/kg IV on days 1 and 15)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Temozolomide (150 mg/m2/day PO on days 1–5) and Irinotecan (50 mg/m2/day IV on days 1–5)
Number of subjects: 105
Study: 32960632

Group type: EXPERIMENTAL
Intervention: Low glycaemic index preparations
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low glycaemic index version of 'Legume with CHO' lunch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High glycaemic index version of 'Chicken with corn' lunch
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low glycaemic index salads
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low glycaemic index desserts
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High glycaemic index main dishes
Number of subjects: 20
Study: 34469766

Group type: EXPERIMENTAL
Intervention: ILR monitoring
Number of subjects: 6004

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 6004
Study: 32517729

Group type: EXPERIMENTAL
Intervention: Lacto-ovo-vegetarian diet (VD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with butyrate (MD-Bt)
Number of subjects: 90
Study: 32680804

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Strength Training (IMST)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Expiratory Muscle Strength Training (EMST)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Vocal Function Exercises (VFE)
Number of subjects: 12
Study: 34227397

Group type: COMPARATOR
Intervention: No beta-blocker
Number of subjects: 6077

Group type: COMPARATOR
Intervention: >0% to 12.5% beta-blocker dose
Number of subjects: 6077

Group type: COMPARATOR
Intervention: >25% to 50% beta-blocker dose
Number of subjects: 6077

Group type: EXPERIMENTAL
Intervention: >12.5% to 25% beta-blocker dose
Number of subjects: 6077

Group type: COMPARATOR
Intervention: Full-dose beta-blocker
Number of subjects: 6077
Study: 32481469

Group type: EXPERIMENTAL
Intervention: Total bile acid to platelet ratio (TPR)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Aspartate aminotransferase to platelet ratio index
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Fibrosis index based on 4 factors
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Red cell distribution width to platelet ratio
Number of subjects: 118
Study: 35436232

Group type: EXPERIMENTAL
Intervention: Barriers module
Number of subjects: 811

Group type: EXPERIMENTAL
Intervention: Barriers module completion
Number of subjects: 811
Study: 35231678

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 375

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 375
Study: 32072344

Group type: EXPERIMENTAL
Intervention: Glycine powder/air polishing every 30 days (group 1)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Glycine powder/air polishing at baseline and on day 90 (group 2)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Water irrigation every 30 days (group 3)
Number of subjects: 19
Study: 35708758

Group type: EXPERIMENTAL
Intervention: (1 → 3)‐β‐d‐Glucan (BDG) guidance
Number of subjects: 339

Group type: COMPARATOR
Intervention: Targeted antifungal therapy driven by culture results (Control)
Number of subjects: 339
Study: 33348031

Group type: EXPERIMENTAL
Intervention: Palliative long-term abdominal drains (LTADs)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Large volume paracentesis (LVP)
Number of subjects: 14
Study: 32108122

Group type: EXPERIMENTAL
Intervention: Oral 50 mg tramadol
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 33801247

Group type: EXPERIMENTAL
Intervention: Ketogenic low-carbohydrate high-fat (LCHF) diet (4% carbohydrates; 77% fat; 19% protein)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ketogenic low-carbohydrate high-fat (LCHF) diet
Number of subjects: 24

Group type: COMPARATOR
Intervention: National Food Agency recommended control diet (44% carbohydrates; 33% fat; 19% protein)
Number of subjects: 24
Study: 32348306

Group type: EXPERIMENTAL
Intervention: Varenicline tartrate plus Quitline-counselling (n = 196)
Number of subjects: 392

Group type: COMPARATOR
Intervention: Quitline-counselling alone (n = 196)
Number of subjects: 392
Study: 34605192

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36273312

Group type: EXPERIMENTAL
Intervention: High Intensity Intermittent Training (HIIT), n=15
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined Training (COM), n=15
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group, n=15
Number of subjects: 45
Study: 34748549

Group type: EXPERIMENTAL
Intervention: Cognition-Targeted Exercise (CTE) with Cognitive Behavior Therapy (CBT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Symptom-Targeted Exercise (STE) with Cognitive Behavior Therapy (CBT)
Number of subjects: 60
Study: 35639197

Group type: EXPERIMENTAL
Intervention: Siponimod (2 mg/day)
Number of subjects: 779

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 779
Study: 36498624

Group type: EXPERIMENTAL
Intervention: Polaprezinc-containing therapy (PQT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bismuth-containing therapy (BQT)
Number of subjects: 100
Study: 35486296

Group type: EXPERIMENTAL
Intervention: Early Risers intervention
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 240
Study: 34659809

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 64

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 64
Study: 35672572

Group type: EXPERIMENTAL
Intervention: Propranolol (PPL)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Endoscopic variceal ligation (EVL)
Number of subjects: 160
Study: 34065997

Group type: EXPERIMENTAL
Intervention: Elastic abdominal binder applied from postoperative day 1
Number of subjects: 109

Group type: COMPARATOR
Intervention: No abdominal binder or similar devices
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Elastic abdominal binder applied from postoperative day 1 (age ≥ 50 subgroup)
Number of subjects: 109

Group type: COMPARATOR
Intervention: No abdominal binder or similar devices (age ≥ 50 subgroup)
Number of subjects: 109